Annotation Detail for PDE3A

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04914 | Progesterone-mediated oocyte maturation |
hsa04910 | Insulin signaling pathway |
hsa00230 | Purine metabolism |
Pathway ID | Pathway Name |
---|
| Signaling by GPCR |
| Hemostasis |
Desease Name |
---|
CARDIOVASCULAR |
height |
QT interval |
male infertility |
Aortic root size |
DEVELOPMENTAL |
REPRODUCTION |
Desease Name |
---|
Height |
QT interval |
Male infertility |
Aortic root size |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PDE3A mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PDE3A mRNA | decreases expression | 19150397
|
D015124 |
8-Bromo Cyclic Adenosine Monophosphate |
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PDE3A mRNA | increases expression | 12466227
|
D003976 |
Diazinon |
Diazinon affects the expression of PDE3A mRNA | affects expression | 17452286
|
C459562 |
L-826,141 |
L-826,141 results in decreased activity of PDE3A protein | decreases activity | 15901792
|
C059498 |
olprinone |
olprinone results in decreased activity of PDE3A protein | decreases activity | 16325808
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PDE3A mRNA | affects binding|increases activity|increases expression | 19710929
|
C424423 |
Roflumilast |
Roflumilast results in decreased activity of PDE3A protein | decreases activity | 15901792
|
C035964 |
trequinsin |
trequinsin results in decreased activity of PDE3A protein | decreases activity | 15901792
|
C081489 |
valsartan |
valsartan results in increased expression of PDE3A mRNA | increases expression | 19027736
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.80 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.30 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.72 | 16434500 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
4.57 | 16487989 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.32 | 19483382 |
MESH:D006332 |
Cardiomegaly |
|
valsartan |
4.27 | 19597038 |
MESH:D009202 |
Cardiomyopathies |
|
valsartan |
4.54 | 16247790 |
MESH:D002318 |
Cardiovascular Diseases |
|
valsartan |
4.41 | 11230374 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.84 | 20889678 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.95 | 19176532 |
MESH:D003324 |
Coronary Artery Disease |
|
valsartan |
3.95 | 17719468 |
MESH:D003384 |
Coxsackievirus Infections |
|
valsartan |
6.08 | 20392896 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.49 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
valsartan |
4.74 | 11508273 |
MESH:D003928 |
Diabetic Nephropathies |
|
valsartan |
4.94 | 11427623 18630688 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
5.06 | 16487989 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.65 | 12083418 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.11 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
2.93 | 19236843 20131406 |
MESH:D005355 |
Fibrosis |
|
valsartan |
4.98 | 16893502 |
MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
valsartan |
5.74 | 16928621 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.72 | 20558911 |
MESH:D006333 |
Heart Failure |
|
valsartan |
7.72 | 19027736 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
4.77 | 16487989 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.21 | 19176532 16221962 19772884 18467677 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.34 | 20558911 |
MESH:D006973 |
Hypertension |
|
valsartan |
3.78 | 16475468 18344623 11427623 20102058 10903974 12850387 18390891 12692753 |
MESH:D006974 |
Hypertension, Malignant |
|
valsartan |
6.68 | 11560862 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
3.93 | 12948887 16466525 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.74 | 16306350 |
MESH:D007674 |
Kidney Diseases |
|
valsartan |
4.05 | 10903974 12164870 16893502 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.85 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
valsartan |
2.85 | 15504291 15619341 16872305 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.87 | 16377806 15890375 20007298 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.72 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
marker/mechanism |
|
| 19027736 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.20 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.08 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.02 | 17405874 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D011041 |
Poisoning |
|
Diazinon |
4.53 | 17603234 |
MESH:D011507 |
Proteinuria |
|
valsartan |
5.04 | 17664856 18344623 12164870 |
MESH:D011658 |
Pulmonary Fibrosis |
|
valsartan |
3.87 | 17241526 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.46 | 19058328 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
5.54 | 16487989 |
MESH:D020257 |
Ventricular Remodeling |
|
valsartan |
5.94 | 19027736 |
PharmGKB Accession:PA33126
Releated disease ID |
Related disease Name |
PA447321 | Depressive Disorder, Major |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00235 |
inhibitor |
Milrinone |
Vasodilator Agents;Platelet Aggregation Inhibitors;Phosphodiesterase Inhibitors;Cardiotonic Agents |
DB00261 |
inhibitor |
Anagrelide |
Antithrombotic Agents;Platelet Aggregation Inhibitors;Fibrinolytic Agents |
DB00277 |
antagonist |
Theophylline rougier elixir |
Vasodilator Agents;Phosphodiesterase Inhibitors;Bronchodilator Agents;Respiratory Smooth Muscle Relaxants |
DB00922 |
antagonist |
Levosimendan |
Vasodilator Agents;Phosphodiesterase Inhibitors;Cardiotonic Agents;Anti-Arrhythmia Agents |
DB01166 |
antagonist |
Cilostazol |
Vasodilator Agents;Platelet Aggregation Inhibitors;Fibrinolytic Agents;Phosphodiesterase Inhibitors;Bronchodilator Agents;Neuroprotective Agents |
DB01223 |
antagonist |
Quiex-Pred Sus |
Phosphodiesterase Inhibitors;Bronchodilator Agents;Cardiotonic Agents;Respiratory Smooth Muscle Relaxants |
DB01303 |
antagonist |
Oxtriphylline |
Bronchodilator Agents |
DB01427 |
antagonist |
Amrinone |
Vasodilator Agents;Phosphodiesterase Inhibitors;Cardiotonic Agents;Calcium Channel Blockers |
DB04880 |
antagonist |
Enoximone |
Vasodilator Agents;Phosphodiesterase Inhibitors;Cardiotonic Agents |
DB05266 |
antagonist |
Ibudilast |
Vasodilator Agents;Platelet Aggregation Inhibitors;Phosphodiesterase Inhibitors;Bronchodilator Agents |
DB08811 |
inhibitor |
Tofisopam |
Benzodiazepines |